Hologic (NSDQ:HOLX) has launched its Fluoroscan InSight FD Mini-Arm product, which is designed to help orthopedists, podiatrists and clinicians capture high-resolution images of their patients’ extremities. The system has low-dose rate modes that allow physicians to cut dose rates by up to 50% compared to auto-mode. It also features a MegaView Image setting in Review Mode, […]
Imaging
Canon inks MR dev deal with Quality Electrodynamics
Canon (NYSE:CAJ) Medical Systems said today it inked a deal to develop new magnetic resonance technologies with Mayfield Village, Ohio’s Quality Electrodynamics Research Center. As part of the deal, Canon Medical Systems said it installed a Vantage Galan 3 Tesla MR system at QED’s new research center to be used in efforts to develop new MR technologies, […]
Varian Medical Systems beats The Street with Q1 earnings
Varian Medical (NYSE:VAR) yesterday topped the consensus earnings forecast on Wall Street with its fiscal first-quarter results, despite a slide into red ink, sending share prices up today in pre-market trading. The Palo Alto, Calif.-based company posted losses of -$112.2 million, or -$1.22 per share, on sales of $678.5 million for the three months ended Dec. […]
AngioDynamics wins FDA fast track for NanoKnife
AngioDynamics (NSDQ:ANGO) yesterday said the FDA granted a fast-track designation for its NanoKnife device for treating Stage III pancreatic cancer. The federal safety watchdog’s Expedited Access Pathway is designed to speed medical devices through the approval process to treat conditions with no available alternatives. The EAP program will transition to the Breakthrough Devices Program once the […]
Philips launches patient monitoring suite in US, imaging devices in India
Royal Philips (NYSE:PHG) said this month it launched its next-generation patient monitoring solutions in the US, as well as releasing a slew of imaging devices into the Indian market. The Amsterdam-based company said it released an enterprise-wide system of bedside, transport, mobile and central station monitoring technology in the US, including the IntelliVue X3 transport monitor. […]
Imagin Medical enrolls 1st patients in i/Blue Imaging study
Imaging solution developer Imagin Medical said yesterday it recruited the initial subjects in a first-in-human study of its i/Blue Imaging System. The company is developing the ultrasensitive i/Blue Imaging System which it hopes will “establish a new standard of care” for detecting certain cancers and visualizing the surgical field during minimally invasive surgery, with an initial focus […]
Bracco Imaging explores using microbubbles to deliver personalized gene therapy
Bracco Imaging has launched a new effort at its Switzerland-based R&D center to evaluate gas-filled microbubbles, usually used for diagnostic imaging, as a delivery vehicle for personalized gene therapies to treat chronic dysfunctional diseases linked to lipid metabolism. The research project is part of a deal that Bracco signed with startup SonoGene, which is developing platforms […]
BioAdvance drops $3.2m on device, drug bets
Early-stage life science fund BioAdvance announced that it has added an array of new companies to its portfolio, investing nearly $3.2 million into companies from the mid-Atlantic region of the U.S. Two of the firm’s largest investments went to Opsidio, a Bryn Mawr, Penn.-based company developing monoclonal antibodies to treat fibrotic diseases, and New York-based Pillo Health, […]
Hologic launches $1B debt offering
Hologic (NSDQ:HOLX) plans to launch a $1 billion private offering made up of 4.375% senior notes due 2025 and new senior notes due 2028. The company reported that it plans to use its available cash, the offering’s proceeds and funds from a revolving credit facility to redeem $1 billion of outstanding 5.25% senior notes due in […]
Aprinoia raises $11m for Alzheimer’s imaging, therapy programs
Aprinoia Therapeutics said today that it has raised $11.1 million in a Series B round, led by KTB Network and DCI Partners. The Taiwan-based biotech plans to use its new funds to advance the preclinical and clinical development of its tau PET imaging tracer and therapy programs for people with Alzheimer’s disease. Get the full story […]
Guerbet to pay $23.7m for Accurate Medical Therapeutics
Contrast agent-maker Guerbet (EPA:GBT) has inked a €19.5 million ($23.7m USD) deal to acquire Israeli medtech company Accurate Medical Therapeutics. Accurate has developed two series of microcatheters designed for embolization procedures of tumors and vascular aneurysms. The first set of catheters optimize the product’s ability to access hard-to-reach lesions and navigate tortuous vascular networks. The second […]